Three independent discounted-cash-flow-style models value Neuropace, Inc. Common Stock every trading day. 0 of 3 currently price NPCE above its market price.
| Free Cash Flow model | $-30.53 |
| Excess Profit model | $-41.12 |
| Residual Earnings model | $-0.03 |
| Dividend Discount model | — |
| Piotroski F-Score | 4 / 9 |
| Return on invested capital | -24.5% |
| Net debt / EBITDA | — |
| Gross margin | +77.2% |
| Revenue CAGR | +30.0% |
| Cash conversion | — |
| Dividend yield | — |
| Buyback yield | -12.3% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open NPCE in StockKitty